Acutus Medical (AFIB) Competitors $0.0001 0.00 (0.00%) As of 05/22/2026 09:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsOptions ChainSEC FilingsTrendsBuy This Stock AFIB vs. UTRS, MOTS, DRTSW, ANZUW, and HSCSWShould you buy Acutus Medical stock or one of its competitors? MarketBeat compares Acutus Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Acutus Medical include Minerva Surgical (UTRS), Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. AFIB vs. UTRSAFIB vs. MOTSAFIB vs. DRTSWAFIB vs. ANZUWAFIB vs. HSCSWHow does Acutus Medical compare to Minerva Surgical?Minerva Surgical (NASDAQ:UTRS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, dividends, earnings, media sentiment and risk. Does the media refer more to UTRS or AFIB? In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment Minerva Surgical Neutral Acutus Medical Neutral Do insiders & institutionals hold more shares of UTRS or AFIB? 56.9% of Acutus Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by insiders. Comparatively, 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has preferable valuation & earnings, UTRS or AFIB? Minerva Surgical has higher revenue and earnings than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMinerva Surgical$51.69M0.00-$34.11M-$4.21N/AAcutus Medical$7.16M0.00-$81.66M-$0.11N/A Which has more risk and volatility, UTRS or AFIB? Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the broader market. Comparatively, Acutus Medical has a beta of 6.08, suggesting that its stock price is 508% more volatile than the broader market. Is UTRS or AFIB more profitable? Minerva Surgical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Minerva Surgical's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Minerva SurgicalN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% SummaryMinerva Surgical beats Acutus Medical on 7 of the 10 factors compared between the two stocks.How does Acutus Medical compare to Motus GI?Motus GI (NASDAQ:MOTS) and Acutus Medical (NASDAQ:AFIB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership. Do insiders & institutionals believe in MOTS or AFIB? 20.1% of Motus GI shares are held by institutional investors. Comparatively, 56.9% of Acutus Medical shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 5.2% of Acutus Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is MOTS or AFIB more profitable? Motus GI has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Motus GI's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Motus GIN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% Which has more risk and volatility, MOTS or AFIB? Motus GI has a beta of 0.81, meaning that its share price is 19% less volatile than the broader market. Comparatively, Acutus Medical has a beta of 6.08, meaning that its share price is 508% more volatile than the broader market. Does the media refer more to MOTS or AFIB? In the previous week, Motus GI's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment Motus GI Neutral Acutus Medical Neutral Which has stronger earnings and valuation, MOTS or AFIB? Motus GI has higher earnings, but lower revenue than Acutus Medical. Acutus Medical is trading at a lower price-to-earnings ratio than Motus GI, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMotus GI$319K0.00-$12.87M-$14.69N/AAcutus Medical$7.16M0.00-$81.66M-$0.11N/A SummaryMotus GI and Acutus Medical tied by winning 5 of the 10 factors compared between the two stocks.How does Acutus Medical compare to Alpha Tau Medical?Alpha Tau Medical (NASDAQ:DRTSW) and Acutus Medical (NASDAQ:AFIB) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk. Do institutionals & insiders hold more shares of DRTSW or AFIB? 56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Is DRTSW or AFIB more profitable? Alpha Tau Medical has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Alpha Tau Medical's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Alpha Tau MedicalN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% Does the media favor DRTSW or AFIB? In the previous week, Alpha Tau Medical's average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment Alpha Tau Medical Neutral Acutus Medical Neutral Which has higher earnings and valuation, DRTSW or AFIB? Alpha Tau Medical has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Tau MedicalN/AN/AN/AN/AN/AAcutus Medical$7.16M0.00-$81.66M-$0.11N/A SummaryAlpha Tau Medical and Acutus Medical tied by winning 3 of the 6 factors compared between the two stocks.How does Acutus Medical compare to Anzu Special Acquisition Corp I?Acutus Medical (NASDAQ:AFIB) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership. Does the media refer more to AFIB or ANZUW? In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score. Company Overall Sentiment Acutus Medical Neutral Anzu Special Acquisition Corp I Neutral Do insiders and institutionals believe in AFIB or ANZUW? 56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is AFIB or ANZUW more profitable? Anzu Special Acquisition Corp I has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Anzu Special Acquisition Corp I's return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Acutus Medical-272.74% -311.64% -11.57% Anzu Special Acquisition Corp I N/A N/A N/A Which has higher earnings and valuation, AFIB or ANZUW? Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAcutus Medical$7.16M0.00-$81.66M-$0.11N/AAnzu Special Acquisition Corp IN/AN/AN/AN/AN/A SummaryAcutus Medical and Anzu Special Acquisition Corp I tied by winning 3 of the 6 factors compared between the two stocks.How does Acutus Medical compare to Heart Test Laboratories?Heart Test Laboratories (NASDAQ:HSCSW) and Acutus Medical (NASDAQ:AFIB) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, media sentiment, risk, dividends and earnings. Do insiders & institutionals have more ownership in HSCSW or AFIB? 56.9% of Acutus Medical shares are owned by institutional investors. 5.2% of Acutus Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media favor HSCSW or AFIB? In the previous week, Heart Test Laboratories' average media sentiment score of 0.00 equaled Acutus Medical'saverage media sentiment score. Company Overall Sentiment Heart Test Laboratories Neutral Acutus Medical Neutral Which has better valuation and earnings, HSCSW or AFIB? Heart Test Laboratories has higher earnings, but lower revenue than Acutus Medical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$8.67KN/AN/AN/AN/AAcutus Medical$7.16M0.00-$81.66M-$0.11N/A Is HSCSW or AFIB more profitable? Heart Test Laboratories has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. Heart Test Laboratories' return on equity of 0.00% beat Acutus Medical's return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A N/A N/A Acutus Medical -272.74%-311.64%-11.57% SummaryHeart Test Laboratories and Acutus Medical tied by winning 3 of the 6 factors compared between the two stocks. Get Acutus Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AFIB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding AFIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AFIB vs. The Competition ExportMetricAcutus MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3K$53.33M$6.45B$12.34BDividend YieldN/A1.08%2.76%5.28%P/E Ratio0.0018.6821.2225.65Price / Sales0.0037.51553.9286.28Price / CashN/A18.8743.4956.67Price / Book0.0016.1510.377.14Net Income-$81.66M-$20.25M$3.57B$335.98M7 Day PerformanceN/A2.29%6.01%3.56%1 Month PerformanceN/A-12.00%3.52%2.54%1 Year PerformanceN/A-2.39%34.13%35.05% Acutus Medical Competitors List ExportCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AFIBAcutus MedicalN/A$0.00flatN/A-99.0%$3K$7.16MN/A340UTRSMinerva SurgicalN/A$0.00+∞N/AN/A$1K$51.69MN/A160Gap UpMOTSMotus GIN/AN/AN/AN/A$1K$319KN/A30DRTSWAlpha Tau MedicalN/A$2.95+9.7%N/AN/A$0.00N/AN/A80ANZUWAnzu Special Acquisition Corp IN/A$0.06-10.0%N/A-1.3%$0.00N/AN/A2Gap Down Related Companies and Tools Related Companies UTRS Competitors MOTS Competitors DRTSW Competitors ANZUW Competitors HSCSW Competitors BEATW Competitors LUCYW Competitors IINNW Competitors NXGLW Competitors NVACW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AFIB) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acutus Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Acutus Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
